SCHEMBL4366985

SCHEMBL4366985

c1ccc2c(-n3nnc4cccnc43)ncnc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.49
RAB9A P51151 2/20 0.45
ALDH1A1 P00352 2/20 0.45
PTK2 Q05397 1/20 0.44
HRH4 Q9H3N8 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 2/20 0.41
TSHR P16473 1/20 0.40
HRH1 P35367 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
PI4KA P42356 1/20 0.40
PI4K2B Q8TCG2 1/20 0.40
PI4K2A Q9BTU6 1/20 0.40
PI4KB Q9UBF8 1/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.39
SORD Q00796 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3978434 0.81 ALDH1A1 (0.65) LMNARAB9AALDH1A1PTK2HRH4
SCHEMBL11851657 0.75 KDM4E (0.50) RAB9AALDH1A1SMN1; SMN2TSHRKDM4E
SCHEMBL3978381 0.74 RAB9A (0.41) LMNARAB9ASMN1; SMN2HTTTSHR
SCHEMBL11846190 0.70 ALDH1A1 (0.44) RAB9AALDH1A1KDM4E
SCHEMBL11853749 0.70 KCNMA1 (0.61) LMNARAB9AALDH1A1HTTKDM4E
SCHEMBL11843568 0.70 RAB9A (0.41) RAB9AALDH1A1KDM4EMAPT
SCHEMBL11846894 0.69 TUBB4A (0.49) LMNARAB9AALDH1A1SMN1; SMN2PDE4B
SCHEMBL11852236 0.67 MAPT (0.46) LMNARAB9ASMN1; SMN2TSHRKDM4E
SCHEMBL11841663 0.67 KCNN4 (0.45) LMNARAB9AALDH1A1SMN1; SMN2TSHR
SCHEMBL3875716 0.66 PI4KA (0.62) LMNARAB9AALDH1A1PTK2HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090291971-A1 HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION WYETH (US) 2009-11-26 US disclosed
US-20090291971-A1 HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION WYETH (US) 2009-11-26 US disclosed
US-20090291971-A1 HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION WYETH (US) 2009-11-26 US disclosed
EP-2075495-A1 Multilayer article Nissan Motor Co., Ltd. (JP) 2009-07-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291971-A1 HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION AHR, MALT1, ABL1 LMNA 1994/4885RAB9A 3568/4885ALDH1A1 1591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.